Skip to main content

Want a detailed portfolio tracker?

Artelo Biosciences (ARTL) P/E (2017 - 2026)

Artelo Biosciences (ARTL) P/E from Nov 14, 2017 to Jul 20, 2026. The TTM Artelo Biosciences (ARTL) P/E is -0.10. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Artelo Biosciences (ARTL)

YearP/EChange
2026-0.10-67.44%
2025-0.31-85.07%
2024-2.10-67.29%
2023-6.43-51.38%
2022-13.22-42.88%
2021-23.15+101.93%
2020-11.47-77.13%
2019-50.14-95.89%
2018-1.22K+15.00%
2017-1.06KN/A

Comparison Artelo Biosciences (ARTL) P/E with competitors

Artelo Biosciences (ARTL) P/E is -0.10.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.66%
NBYStablecoin Development Corp0.00-104.20%
ENLVEnlivex Ltd0.07-173.14%
FGENFibroGen Inc0.24-334.71%
CHRSCoherus Biosciences Inc0.85-929.67%
FBIOFortress Biotech Inc0.95-1027.94%
ORMPOramed Pharmaceuticals Inc1.50-1569.64%
AGENAgenus Inc3.01-3042.70%
INVAInnoviva Inc3.15-3183.90%
VXRTVaxart Inc3.55-3570.81%
CRMDCorMedix Inc3.63-3647.77%
CVACCureVac N.V.4.45-4446.83%
GLPGGalapagos NV4.86-4850.86%
SRPTSarepta Therapeutics Inc4.88-4873.54%
ABEOAbeona Therapeutics Inc5.39-5367.72%
ABUSArbutus Biopharma Corp5.60-5571.21%
ZVRAZevra Therapeutics Inc5.89-5856.33%
SPROSpero Therapeutics Inc6.23-6189.96%
CGENCompugen Ltd6.31-6273.56%
RIGLRigel Pharmaceuticals6.87-6819.28%
SLXNSilexion Therapeutics Corp7.30-7233.86%
OMEROmeros Corporation9.26-9152.90%
AUPHAurinia Pharmaceuticals Inc9.58-9471.86%
PLXProtalix BioTherapeutics Inc10.89-10748.87%
ACADAcadia Pharmaceuticals Inc11.73-11567.79%
TBPHTheravance Biopharma Inc12.26-12089.54%
ADMAAdma Biologics Inc12.42-12242.08%
HRMYHarmony Biosciences Holdings Inc13.82-13612.96%
SABSSAB Biotherapeutics Inc14.14-13921.95%
NAGENiagen Bioscience Inc14.82-14588.71%
INCYIncyte Corp15.82-15570.82%
REGNRegeneron Pharmaceuticals Inc15.86-15604.16%
PBYIPuma Biotechnology Inc17.32-17030.78%
CPRXCatalyst Pharmaceuticals Inc17.44-17151.63%
EXELExelixis Inc17.54-17248.14%
TGTXTG Therapeutics Inc18.97-18644.45%
MDXGMimedx Group Inc20.55-20195.64%
XOMAXOMA Royalty Corp22.87-22466.78%
ARGXArgen X SE24.30-23858.49%
CTMXCytomX Therapeutics Inc24.82-24369.98%
XOMAOXOMA Royalty Corp25.34-24882.06%
HALOHalozyme Therapeutics Inc25.62-25154.77%
XOMAPXOMA Royalty Corp25.67-25200.14%
VRTXVertex Pharmaceuticals Inc27.99-27473.14%
RPRXRoyalty Pharma plc - Class A28.69-28150.56%
SLNOSoleno Therapeutics Inc29.02-28471.09%
ASNDAscendis Pharma A/S30.09-29517.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-37170.22%
APLSApellis Pharmaceuticals Inc39.02-38254.80%
BMRNBiomarin Pharmaceutical Inc42.21-41374.58%
KRYSKrystal Biotech Inc45.34-44436.68%
ONCBeiGene Ltd69.54-68096.41%
PHARPharming Group N.V.75.03-73459.76%
TECHBio-Techne Corp101.96-99794.57%
VCELVericel Corp109.92-107580.73%
ALNYAlnylam Pharmaceuticals Inc117.96-115445.89%
GMABGenmab140.29-137275.86%
TLXTelix Pharmaceuticals Ltd162.15-158652.52%
CORTCorcept Therapeutics Inc212.86-208231.40%